TRIMAGE – Development of a Simultaneous Trimodal (PET/MR/EEG) Imaging Tool for Early Diagnosis of Schizophrenia and Other Mental Disorders - 09/06/15
Résumé |
Introduction |
The FP7-European funded project TRIMAGE is run by a European consortium of 7 research institutes and 4 SMEs. It started in December 2013 and has a duration of 4 years. It is coordinated by the Department of Physics ’E. Fermi” of the University of Pisa (Italy),
Objective |
TRIMAGE aims to create a trimodal, cost-effective imaging tool consisting of PET/MR/EEG. It uses cutting edge technology with performance beyond the state of the art. The tool is intended for broad distribution to enable effective early diagnosis of schizophrenia and possibly other mental health disorders.
Methods |
The goals of this project will be achieved by the scientific and technological developments in both the clinical and technological fields, as detailed by the following three strongly correlated S&T sub-objectives:
a) | Find new biomarkers and define a suitable multimodal paradigm with already available PET, MR, EEG and PET/MR systems thus providing clinical evidence on the feasibility of early schizophrenia diagnosis. |
b) | Construct and test an optimized cost-effective trimodality imaging instrument (brain PET/MR/EEG) for diagnosis, monitoring and follow-up of schizophrenia disorders. |
c) | Validate the trimodal imaging device built by this Consortium with regard to the results and the clinical data obtained from sub-objective a). |
Discussion |
This presentation will describe the outlines of the project and will present an update after the first year of running.
Le texte complet de cet article est disponible en PDF.
Vol 30 - N° S1
P. 161 - mars 2015 Retour au numéro
Article précédent
- Stalking and the Law – an Israeli Legal System Based Analysis
- O. Asman
- Need for Training in Cultural Psychiatry-Lessons for Europe
- D. Bhugra
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?